14

Articles

13

Sources

36%

Analysis & opinion

The reporting

A neutral summary of the key facts most outlets agree on, drawn from reporting across the political spectrum.

The Centers for Medicare & Medicaid Services finalized a rule, effective Oct. 13, ending federal Medicaid and Children’s Health Insurance Program funding for gender-affirming care for minors. The rule bars federal payments for puberty blockers, hormone treatments and transition-related surgeries; CHIP coverage is barred for patients under 19. Children already receiving hormone therapy will have a six-month phase-out period. The policy is part of the Trump administration’s broader effort to restrict gender-affirming medical care for transgender and nonbinary youth.

Analysis & opinion

The arguments that emerged from this coverage — built only from the analysis and opinion pieces, never from straight reporting. Each dot is one article, placed by its outlet's bias — left to right. How to read our graphics →
angles sorted left-argued → right-argued

Medicaid care cutoffLeans Left

Ending federal Medicaid and CHIP support for youth gender-affirming care denies vulnerable transgender teenagers medically necessary treatment. The Trump administration is harming low-income transgender children while claiming it is protecting them.

Mother Jones
MS NOW

Taxpayer-funded transition harmsLeans Right

Public money should not support programs or medical procedures that push children toward gender transition. Colorado’s transgender-related initiatives and gender-transition treatments for minors are harmful to children and deserve federal intervention or defunding.

The Federalist
Wall Street Journal

Get tomorrow's edition

Every side, every morning — free in your inbox.

More of today's stories

all of today's stories →